ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
col69
|
9.7K |
2.9M |
5 |
12:32 |
12:32 |
ASX - By Stock
|
9.7K
|
2.9M
|
5
|
|
ASX - By Stock
|
SPL |
Re:
TGA Delegate Final Decision SPL7013 Sched2 1/6/24
|
|
col69
|
7 |
1.5K |
0 |
10:49 |
10:49 |
ASX - By Stock
|
7
|
1.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
col69
|
17K |
6.7M |
19 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
19
|
|
ASX - By Stock
|
SPL |
Re:
Unloved at the moment
|
|
col69
|
36 |
9.5K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
36
|
9.5K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
col69
|
24K |
11M |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
col69
|
24K |
11M |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
col69
|
13K |
6.6M |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
13K
|
6.6M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
col69
|
235 |
78K |
18 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
235
|
78K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
col69
|
235 |
78K |
21 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
235
|
78K
|
21
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
col69
|
25K |
12M |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
25K
|
12M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
col69
|
13K |
6.6M |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
13K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
col69
|
832 |
319K |
18 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
832
|
319K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
col69
|
235 |
78K |
17 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
235
|
78K
|
17
|
|
ASX - By Stock
|
SPL |
Re:
New indications for irinotecan
|
|
col69
|
12 |
2.5K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
12
|
2.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
col69
|
235 |
78K |
10 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
235
|
78K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma Delegation @ ASCO 2024
|
|
col69
|
10 |
2.1K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
10
|
2.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - Cheryl Maley
|
|
col69
|
11 |
2.3K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
11
|
2.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
col69
|
15 |
3.1K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
15
|
3.1K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
col69
|
215 |
51K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
215
|
51K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
col69
|
832 |
319K |
16 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
832
|
319K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
col69
|
832 |
319K |
14 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
832
|
319K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
col69
|
832 |
319K |
19 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
832
|
319K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
col69
|
832 |
319K |
9 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
832
|
319K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
col69
|
24K |
11M |
40 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
24K
|
11M
|
40
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
col69
|
42 |
10K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
10K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
col69
|
42 |
10K |
3 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
10K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
col69
|
42 |
10K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
col69
|
42 |
10K |
3 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
10K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
col69
|
42 |
10K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
10K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
col69
|
9.7K |
2.9M |
22 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
9.7K
|
2.9M
|
22
|
|
ASX - By Stock
|
SPL |
Re:
Annual Report 2024
|
|
col69
|
6 |
1.5K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
6
|
1.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
col69
|
11 |
1.6K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
1.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
col69
|
11 |
1.6K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
1.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
col69
|
9.7K |
2.9M |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
9.7K
|
2.9M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
col69
|
5.3K |
2.6M |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
19
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
col69
|
11 |
1.6K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
1.6K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
col69
|
25K |
12M |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
25K
|
12M
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Bird Flu
|
|
col69
|
4 |
810 |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
4
|
810
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
col69
|
17K |
6.7M |
24 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
17K
|
6.7M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
col69
|
622 |
266K |
9 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
622
|
266K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Salted
|
|
col69
|
3 |
704 |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
3
|
704
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
col69
|
44 |
9.8K |
4 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
44
|
9.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
col69
|
17 |
4.9K |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
4.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
col69
|
17 |
4.9K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
4.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
col69
|
17 |
4.9K |
4 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
4.9K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
col69
|
17 |
4.9K |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
4.9K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
col69
|
17 |
4.9K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
4.9K
|
2
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
col69
|
25K |
12M |
7 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
25K
|
12M
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
col69
|
44 |
9.8K |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
44
|
9.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
col69
|
65 |
29K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
65
|
29K
|
8
|
|